PIER 88 INVESTMENT PARTNERS LLC - DENALI THERAPEUTICS INC ownership

DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 208 filers reported holding DENALI THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.

Quarter-by-quarter ownership
PIER 88 INVESTMENT PARTNERS LLC ownership history of DENALI THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$1,610,771
+96.4%
69,370
+73.6%
0.36%
+78.7%
Q1 2024$820,184
-15.5%
39,970
-11.6%
0.20%
-17.2%
Q4 2023$970,850
-7.2%
45,240
-10.8%
0.24%
-6.5%
Q3 2023$1,045,941
-25.7%
50,700
+6.3%
0.26%
-25.0%
Q2 2023$1,407,037
+42.6%
47,680
+11.3%
0.35%
+45.6%
Q1 2023$987,034
+0.7%
42,840
+21.6%
0.24%
+0.4%
Q4 2022$980,024
+164.2%
35,240
+191.5%
0.24%
+170.5%
Q3 2022$371,000
-3.6%
12,090
-7.6%
0.09%
-3.3%
Q2 2022$385,00013,080
+130700.0%
0.09%
Q1 2022$0
-100.0%
10
-100.0%
0.00%
-100.0%
Q4 2021$1,476,000
+55.0%
33,080
+75.2%
0.31%
+9.4%
Q3 2021$952,000
-14.1%
18,880
+33.7%
0.29%
-10.1%
Q2 2021$1,108,000
+156.5%
14,120
+86.8%
0.32%
+116.3%
Q1 2021$432,000
-59.8%
7,560
-41.1%
0.15%
-57.5%
Q4 2020$1,074,000
-16.2%
12,825
-64.2%
0.35%
-11.1%
Q3 2020$1,282,000
+1.3%
35,795
-31.6%
0.39%
+8.1%
Q2 2020$1,265,000
+51.5%
52,309
+9.7%
0.36%
+18.0%
Q1 2020$835,000
+14.1%
47,700
+13.6%
0.30%
+5.2%
Q4 2019$732,000
+17.7%
42,000
+3.4%
0.29%
+20.3%
Q3 2019$622,000
+8.4%
40,610
+46.9%
0.24%
-1.2%
Q2 2019$574,000
-31.2%
27,650
-23.0%
0.24%
-36.5%
Q1 2019$834,000
+54.4%
35,930
+37.5%
0.38%
+40.1%
Q4 2018$540,000
-34.5%
26,130
-31.1%
0.27%
-23.7%
Q3 2018$825,00037,9300.36%
Other shareholders
DENALI THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Crestline Management, LP 19,462,500$404,042,00054.41%
Bratton Capital Management, L.P. 953,035$19,785,00029.05%
Flagship Pioneering Inc. 8,005,747$166,199,0007.19%
Casdin Capital, LLC 400,000$8,304,000,0000.78%
Temasek Holdings (Private) Ltd 4,410,457$91,561,0000.65%
IRONWOOD INVESTMENT MANAGEMENT LLC 22,595$469,0000.37%
MARK ASSET MANAGEMENT LP 70,532$1,464,0000.34%
Artal Group S.A. 400,000$8,304,0000.34%
PIER 88 INVESTMENT PARTNERS LLC 27,650$574,0000.24%
WASATCH ADVISORS LP 996,147$20,680,0000.20%
View complete list of DENALI THERAPEUTICS INC shareholders